Re-evaluation of polyvinylpyrrolidone (E 1201) and polyvinylpolypyrrolidone (E 1202) as food additives and extension of use of polyvinylpyrrolidone (E 1201).
E 1201
E 1202
food additives
foods for special medical purposes
polyvinylpolypyrrolidone
polyvinylpyrrolidone
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
14
8
2020
pubmed:
14
8
2020
medline:
14
8
2020
Statut:
epublish
Résumé
The present opinion deals with the re-evaluation of polyvinylpyrrolidone (E 1201, PVP) and polyvinylpolypyrrolidone (E 1202, PVPP) when used as food additives. One request for extension of use of PVP (E 1201) in foods for special medical purposes was also considered in this assessment. The Panel followed the conceptual framework under Commission Regulation (EU) No 257/2010 and considered that: the exposure assessment was based on the reported use and use levels (one food category out of the two food categories in which PVP and PVPP are authorised); the 95th percentile of exposure to PVP and PVPP of maximally 23.7 and 25 mg/kg body weight (bw) per day in children, respectively, was overestimated, because it was assumed that 100% of the food supplements consumed contained PVP or PVPP at the maximum reported use levels; the extension of use of PVP (E 1201) to foods for special medical purposes (FC 13.2) would result in an exposure of PVP of 4.3 mg/kg bw per day for children; the absorption of PVP and PVPP is very low; sufficient toxicity data were available for PVP; there is no concern with respect to the genotoxicity of PVP and PVPP; no carcinogenic effects were reported in carcinogenicity studies in rats at a dose of 2,500 mg PVP/kg bw per day, the highest dose tested; there is no need for chronic toxicity/carcinogenicity data for PVPP for the safety assessment of PVPP given the chemical similarity between PVP and PVPP, and the lack of adverse effects in the available repeated dose toxicity studies. Therefore, the Panel concluded that there is no need for numerical acceptable daily intakes (ADIs) for PVP and PVPP, and that there is no safety concern for the reported uses and use levels of PVP and PVPP as food additives. The Panel further concluded that the proposed extension of use is not expected to be of safety concern at the proposed maximum permitted level (MPL) and recommended consumption level.
Identifiants
pubmed: 32788942
doi: 10.2903/j.efsa.2020.6215
pii: EFS26215
pmc: PMC7416752
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e06215Informations de copyright
© 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
Environ Mutagen. 1987;9 Suppl 9:1-109
pubmed: 3552650
Carcinogenesis. 1994 Apr;15(4):733-7
pubmed: 8149488
J Environ Pathol Toxicol. 1980 Sep;4(2-3):327-35
pubmed: 7462908
J Immunol. 2004 Nov 1;173(9):5406-14
pubmed: 15494487
EFSA J. 2017 Jun 15;15(6):e04786
pubmed: 32625504
Natl Toxicol Program Tech Rep Ser. 2004 May;(518):5-163
pubmed: 15213765
Environ Mol Mutagen. 1988;11(1):31-40
pubmed: 3276507
EFSA J. 2017 Oct 05;15(10):e04911
pubmed: 32625282
Mutat Res. 1981 Nov;87(3):211-97
pubmed: 6799817
World Health Organ Tech Rep Ser. 1987;751:1-57
pubmed: 3111105
Bull Exp Biol Med. 2012 May;153(1):64-7
pubmed: 22808496